| Lactose (India) Ltd | 146 Cr. | 116 | 247/84.3 | 32.3 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.33/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,110 Cr. | 377 | 479/192 | 85.1 | 24.3 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 35.5 Cr. | 47.9 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 44.0 Cr. | 30.0 | 30.5/17.0 | 105 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 55.0 Cr. | 73.1 | 134/72.1 | 14.9 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 55,533 Cr. | 1,968 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 328 Cr. | 13.5 | 19.0/10.8 | 19.7 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 19.2/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 885 Cr. | 1,874 | 1,999/635 | 30.6 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 92.6 Cr. | 18.5 | 32.0/17.1 | 25.3 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 792 Cr. | 269 | 449/219 | 7.07 | 133 | 0.93 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.20 Cr. | 2.89 | 9.28/2.11 | 4.09 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 424 Cr. | 437 | 477/142 | 64.1 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,494 Cr. | 1,034 | 1,565/1,022 | 40.7 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.12/0.26 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 39.4 Cr. | 15.0 | 26.3/7.10 | 19.2 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 10.0 Cr. | 9.95 | 17.2/9.00 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 165 Cr. | 463 | 859/443 | 9.37 | 596 | 0.32 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 75.5 Cr. | 75.5 | 92.5/26.1 | 142 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,719 Cr. | 1,408 | 2,452/1,345 | 45.8 | 174 | 0.76 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.2 Cr. | 42.0 | 88.7/36.1 | 41.7 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.8 Cr. | 5.51 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 16.7 Cr. | 111 | 154/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 59.9 Cr. | 110 | 110/9.41 | 41.3 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 26.4 Cr. | 35.0 | 80.0/35.0 | 42.6 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 5.74 Cr. | 19.1 | 26.0/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 9,437 Cr. | 545 | 1,028/492 | 26.8 | 72.4 | 0.22 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 83.9 Cr. | 19.4 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.0 Cr. | 21.7 | 43.7/17.4 | 47.9 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 90,960 Cr. | 2,206 | 3,055/2,115 | 54.6 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 210 Cr. | 364 | 524/241 | 21.5 | 123 | 1.24 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 58.8 Cr. | 41.0 | 62.6/26.7 | 91.9 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,687 Cr. | 1,218 | 1,365/994 | 20.6 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 160 Cr. | 256 | 303/159 | 152 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 826 Cr. | 82.2 | 123/74.0 | 21.3 | 32.6 | 1.82 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 36.9 Cr. | 28.3 | 49.7/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,965 Cr. | 1,708 | 1,902/919 | 62.4 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.89 Cr. | 0.59 | 1.45/0.55 | 97.4 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 213 Cr. | 27.8 | 68.0/27.0 | 13.6 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 4.45 Cr. | 7.60 | 22.2/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 121 Cr. | 5.15 | 6.57/2.82 | 282 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 61,558 Cr. | 28,945 | 37,000/25,260 | 40.8 | 1,888 | 1.64 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,545 Cr. | 722 | 972/550 | 27.3 | 226 | 0.69 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 210 Cr. | 75.6 | 100/31.3 | 58.7 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,839 Cr. | 1,579 | 1,740/603 | | 103 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 22,108 Cr. | 1,360 | 1,870/1,110 | 403 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 837 Cr. | 239 | 330/154 | 19.5 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 1,011 Cr. | 745 | 808/270 | 16.0 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,113 Cr. | 446 | 839/438 | 21.4 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,529 Cr. | 1,087 | 1,595/991 | 21.6 | 768 | 0.92 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,27,926 Cr. | 3,786 | 3,882/2,886 | 59.0 | 250 | 0.85 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 975 Cr. | 106 | 297/98.0 | | 41.3 | 0.47 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,422 Cr. | 15.1 | 24.0/14.1 | 22.6 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 20,756 Cr. | 543 | 1,342/534 | 60.4 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,876 Cr. | 170 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,33,080 Cr. | 1,805 | 1,910/1,547 | 37.5 | 324 | 0.89 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,455 Cr. | 552 | 810/441 | 383 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,955 Cr. | 317 | 335/175 | 36.4 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 6,477 Cr. | 332 | 502/265 | 41.9 | 125 | 0.15 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,046 Cr. | 200 | 260/111 | 117 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,975 Cr. | 4,330 | 6,718/4,146 | 27.0 | 340 | 2.70 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,653 Cr. | 2,201 | 2,725/1,772 | 32.8 | 335 | 0.91 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,496 Cr. | 5,713 | 6,739/4,904 | 31.0 | 373 | 2.19 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 178 Cr. | 50.5 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 22,866 Cr. | 5,000 | 5,993/3,701 | 32.4 | 841 | 0.70 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 119 Cr. | 96.8 | 242/81.0 | 12.3 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,123 Cr. | 344 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,401 Cr. | 868 | 1,998/604 | 84.2 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 21,674 Cr. | 16,887 | 19,748/10,060 | 111 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 470 Cr. | 21.0 | 44.9/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,729 Cr. | 934 | 1,505/660 | 10.9 | 483 | 0.64 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,327 Cr. | 42.5 | 91.7/41.7 | 30.8 | 21.8 | 0.47 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,311 Cr. | 184 | 348/162 | 23.6 | 59.3 | 0.43 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 40.2 Cr. | 25.3 | 130/23.9 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 279 Cr. | 78.0 | 177/76.2 | 137 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 95,815 Cr. | 2,098 | 2,403/1,774 | 22.2 | 430 | 0.57 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 984 Cr. | 493 | 980/490 | 12.3 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 55,436 Cr. | 1,026 | 1,040/501 | 81.2 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 934 Cr. | 900 | 1,235/596 | 19.0 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 152 Cr. | 69.0 | 116/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 652 Cr. | 135 | 227/123 | 37.0 | 104 | 2.23 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 597 Cr. | 343 | 500/265 | 21.6 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,074 Cr. | 1,074 | 1,250/802 | 34.4 | 414 | 0.46 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,602 Cr. | 1,827 | 1,952/1,303 | 39.8 | 243 | 0.85 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,398 Cr. | 209 | 302/193 | 32.0 | 38.0 | 1.19 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 36,473 Cr. | 1,440 | 1,758/1,168 | 36.8 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,492 Cr. | 84.9 | 127/57.5 | 21.5 | 59.7 | 0.94 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 787 Cr. | 96.2 | 124/67.2 | 26.6 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,319 Cr. | 251 | 350/190 | | 106 | 0.08 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,988 Cr. | 242 | 457/217 | 296 | 96.9 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,414 Cr. | 1,649 | 2,606/1,243 | 32.3 | 397 | 0.42 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,573 Cr. | 356 | 498/285 | 65.8 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,673 Cr. | 564 | 621/412 | 26.8 | 164 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 55,464 Cr. | 1,966 | 2,286/1,275 | 22.1 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,157 Cr. | 2,546 | 3,516/1,921 | 45.3 | 101 | 1.65 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 28,900 Cr. | 1,750 | 2,131/1,200 | 25.0 | 610 | 1.03 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,782 Cr. | 416 | 528/359 | 30.1 | 149 | 1.20 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 21,441 Cr. | 1,572 | 1,910/1,097 | 51.6 | 227 | 0.46 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,06,594 Cr. | 1,277 | 1,406/1,020 | 18.5 | 432 | 0.63 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,511 Cr. | 224 | 322/178 | 23.5 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,22,810 Cr. | 1,521 | 1,673/1,310 | 22.6 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,982 Cr. | 1,972 | 2,641/1,551 | 25.4 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 289 Cr. | 99.4 | 203/95.2 | 20.7 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,800 Cr. | 170 | 191/105 | 16.4 | 107 | 0.29 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 56.4 Cr. | 34.9 | 67.7/32.6 | 19.8 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 52,529 Cr. | 393 | 425/291 | 111 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,648 Cr. | 1,632 | 2,190/1,430 | 36.4 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 114 Cr. | 71.5 | 132/70.0 | 16.6 | 49.2 | 1.68 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 353 Cr. | 149 | 205/67.8 | 33.4 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 23,112 Cr. | 9,230 | 10,691/6,301 | 100.0 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,911 Cr. | 660 | 843/544 | 33.7 | 118 | 0.70 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 168 Cr. | 81.0 | 137/75.2 | 8.93 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,751 Cr. | 5,702 | 5,868/4,492 | 29.2 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 17,721 Cr. | 902 | 1,124/725 | 27.9 | 271 | 1.22 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 436 Cr. | 767 | 1,540/763 | | 690 | 0.65 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 32,799 Cr. | 2,623 | 3,116/2,022 | 33.7 | 345 | 1.07 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,414 Cr. | 305 | 412/258 | 23.2 | 133 | 1.71 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,692 Cr. | 405 | 575/312 | 19.4 | 147 | 0.25 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,585.18 Cr | 1,173.27 | | 52.01 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |